Magellan Health (MGLN) Misses Q2 EPS by 4c

Magellan Health (NASDAQ: MGLN) reported Q2 EPS of $0.58, $0.04 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.15 billion.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print
• Taylor Devices (TAYD) Misses Q4 EPS by 31c